Commenting on"a review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia," by Kantrowitzet al.
Zvosec
Deborah L
DL
Smith
Stephen W
SW
D006801:Humans; D006885:Hydroxybutyrates / Q000009:adverse effects* / Q000627:therapeutic use; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000150:complications*; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000209:etiology / Q000401:mortality*
D006885:Hydroxybutyrates; D006993:Hypnotics and Sedatives; C111420:4-hydroxybutyric acid